Bafna Pharmaceuticals Limited — Others, 16-11-2024: Copy of Newspaper Publication

BAFNA Pharmaceuticals Limited has announced a board meeting to discuss the financial results for the quarter and half-year ended September 30, 2024. The unaudited results were published in newspapers, indicating the company’s continued transparency in financial reporting. This update may reflect positively on investor sentiment as it demonstrates the company’s commitment to timely disclosures, potentially strengthening shareholder trust. Investors might view this as an opportunity for better understanding BAFNA's operational performance, supporting a positive outlook for the company moving forward.